AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Importance of Molecular Testing and Risk Stratification in AML Treatment
This chapter highlights the critical role of molecular and cytogenetic testing in the management of acute myeloid leukemia (AML), focusing on genetic markers that shape treatment strategies. It also discusses how chromosomal abnormalities impact risk stratification and the phases of treatment for patients eligible for intensive chemotherapy.